The Novo Nordisk Foundation is hosting its annual Future of Precision Medicine Symposium which will be attended by PrecisionLife Co-founder & Chief Analytics Officer, Dr Gert Møller.
The Symposium marks major innovations in precision diabetes medicine from cutting-edge research through clinical implementation.
Register for free to join the event online or in-person, visit the Future of Precision Medicine Symposium website.